- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 14th, 2010
Back in the early 1980s, Dr. Patrick Soon-Shiong thought he might be on to something big: a cure for diabetes.
The young UCLA researcher planned to transplant cells that produce insulin into a diabetic's malfunctioning pancreas. Similar efforts had failed, but he believed encasing the cells in a microthin seaweed gel, of all things, would work.
"You're a flake," Soon-Shiong remembers his department chair telling him.
Soon-Shiong's work only "cured" diabetes for a short time, but that research led to the development of the first breast cancer drug based on nanotechnology. Called Abraxane, the drug is credited with saving thousands of lives.
That, in turn, led the surgeon and scientist into the world of entrepreneurship, where he has showed unusual acumen building companies, including one he sold for billions.
|Related News Press|
News and information
Personal cooling units on the horizon April 29th, 2016
Exploring phosphorene, a promising new material April 29th, 2016
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010